Hepatitis Monthly

Published by: Kowsar

Interleukin-18 Gene Promoter Polymorphisms and Susceptibility to Chronic Hepatitis B Infection: A Review Study

Mahsa Motavaf 1 , Saeid Safari 1 , 2 and Seyed Moayed Alavian 1 , 3 , *
Authors Information
1 Department of Molecular Hepatology, Middle East Liver Disease Center (MELD), Tehran, IR Iran
2 Department of Anesthesiology and Pain Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
3 Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Hepatitis Monthly: July 01, 2014, 14 (7); e19879
  • Published Online: July 1, 2014
  • Article Type: Review Article
  • Received: April 30, 2014
  • Accepted: May 1, 2014
  • DOI: 10.5812/hepatmon.19879

To Cite: Motavaf M, Safari S, Alavian S M. Interleukin-18 Gene Promoter Polymorphisms and Susceptibility to Chronic Hepatitis B Infection: A Review Study, Hepat Mon. 2014 ;14(7):e19879. doi: 10.5812/hepatmon.19879.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
2. Evidence Acquisition
3. Results
4. Conclusions
Footnotes
References
  • 1. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
  • 2. Ganji A, Esmaeilzadeh A, Ghafarzadegan K, Helalat H, Rafatpanah H, Mokhtarifar A. Correlation between HBsAg quantitative assay results and HBV DNA levels in chronic HBV. Hepat Mon. 2011; 11(5): 342-5[PubMed]
  • 3. Mohebbi SR, Sanati A, Cheraghipour K, Rostami Nejad M, Shalmani HM, Zali MR. Hepatitis C and hepatitis B virus infection: epidemiology and risk factors in a large cohort of pregnant women in Lorestan, West of Iran. Hepat Mon. 2011; 11(9): 736-9[DOI][PubMed]
  • 4. Thio CL, Thomas DL, Carrington M. Chronic viral hepatitis and the human genome. Hepatology. 2000; 31(4): 819-27[DOI][PubMed]
  • 5. Arababadi MK, Mohammadzadeh A, Pourfathollah AA, Kennedy D. Polymorphisms within Fas gene are not associated with occult hepatitis B virus infection: Polymorphisms within Fas gene in occult HBV infection. Hepat Mon. 2011; 11(1): 23-6[PubMed]
  • 6. Abel L, Dessein AJ. Genetic epidemiology of infectious diseases in humans: design of population-based studies. Emerg Infect Dis. 1998; 4(4): 593-603[DOI][PubMed]
  • 7. He YL, Zhao YR, Zhang SL, Lin SM. Host susceptibility to persistent hepatitis B virus infection. World J Gastroenterol. 2006; 12(30): 4788-93[PubMed]
  • 8. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol. 1995; 99(2): 303-10[PubMed]
  • 9. Sharafi H, Pouryasin A, Alavian SM, Behnava B, Keshvari M, Salimi S, et al. Distribution of IL28B Genotypes in Iranian Patients with Chronic Hepatitis C and Healthy Individuals. Hepat Mon. 2012; 12(12)[DOI][PubMed]
  • 10. Wu L, Chen L, Zhou L, Xie H, Wei B, Yin S, et al. Association of interleukin 18 gene promoter polymorphisms with HBV recurrence after liver transplantation in Han Chinese population. Hepat Mon. 2011; 11(6): 469-74[PubMed]
  • 11. Li W, Jiang Y, Jin Q, Shi X, Jin J, Gao Y, et al. Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population. Liver Int. 2011; 31(8): 1118-26[DOI][PubMed]
  • 12. Wang S, Huang D, Sun S, Ma W, Zhen Q. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa. Virol J. 2011; 8: 28[DOI][PubMed]
  • 13. Zecchina G, Novick D, Rubinstein M, Barak V, Dinarello C, Nagler A. Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants. J Hematother Stem Cell Res. 2001; 10(6): 769-76[DOI][PubMed]
  • 14. Kieszko R, Krawczyk P, Jankowska O, Chocholska S, Krol A, Milanowski J. The clinical significance of interleukin 18 assessment in sarcoidosis patients. Respir Med. 2007; 101(4): 722-8[DOI][PubMed]
  • 15. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001; 19: 423-74[DOI][PubMed]
  • 16. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today. 2000; 21(7): 312-5[PubMed]
  • 17. Kalina U, Ballas K, Koyama N, Kauschat D, Miething C, Arnemann J, et al. Genomic organization and regulation of the human interleukin-18 gene. Scand J Immunol. 2000; 52(6): 525-30[PubMed]
  • 18. Tone M, Thompson SA, Tone Y, Fairchild PJ, Waldmann H. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J Immunol. 1997; 159(12): 6156-63[PubMed]
  • 19. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol. 2001; 112(1-2): 146-52[PubMed]
  • 20. Arimitsu J, Hirano T, Higa S, Kawai M, Naka T, Ogata A, et al. IL-18 gene polymorphisms affect IL-18 production capability by monocytes. Biochem Biophys Res Commun. 2006; 342(4): 1413-6[DOI][PubMed]
  • 21. Bouzgarrou N, Hassen E, Schvoerer E, Stoll-Keller F, Bahri O, Gabbouj S, et al. Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection. J Med Virol. 2008; 80(4): 607-14[DOI][PubMed]
  • 22. Sobti R, Sharma V, Abitew A, Berhane N, Mahdi S, Askari M, et al. IL-18 Gene Promoter Region 607C/A Polymorphism in HIV-1 Infected North Indian Population. Balkan J Med Genet : BJMG. 2011; 14(2): 41-8[DOI][PubMed]
  • 23. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol. 2002; 76(21): 10702-7[PubMed]
  • 24. Sun Y, Chen HY, Wang F, Zhang X, Jiang HQ, Shao FJ, et al. [Effect of IL-18 on peripheral blood monocytes from chronic hepatitis B patients]. Zhonghua Gan Zang Bing Za Zhi. 2003; 11(8): 470-3[PubMed]
  • 25. Zhang PA, Wu JM, Li Y, Yang XS. [Relationship of interleukin-18 gene promoter polymorphisms with chronic hepatitis B in Chinese Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005; 22(5): 528-32[PubMed]
  • 26. Hirankarn N, Manonom C, Tangkijvanich P, Poovorawan Y. Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens. 2007; 70(2): 160-3[DOI][PubMed]
  • 27. Li N, Gao YF, Zhang TC, Chen P, Li X, Su F. Relationship between interleukin 18 polymorphisms and susceptibility to chronic hepatitis B virus infection. World J Hepatol. 2012; 4(3): 105-9[DOI][PubMed]
  • 28. Khripko OP, Sennikova NS, Lopatnikova JA, Khripko JI, Filipenko ML, Khrapov EA, et al. Association of single nucleotide polymorphisms in the IL-18 gene with production of IL-18 protein by mononuclear cells from healthy donors. Mediators Inflamm. 2008; 2008: 309721[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments